SkinHealth Systems Inc.

Greetings and welcome to the Beauty Health Third Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during today's conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn this conference over to your host, Ms. Dawn Frankfurt, Managing Director at ICR. Thank you, ma'am. You may begin your presentation.

Good afternoon, everyone. Thank you for joining the Beauty Health Company's conference call to discuss the company's third quarter 2021 financial results, which we released this afternoon and can be found on our website at investors.beautyhealth.com. With me on the call is Brent Saunders, Executive Chairman, Clint Carnell, Chief Executive Officer, and Leanne Wu, Chief Financial Officer of the Beauty Health Company. Before we get started, I would like to remind you of the company's safe harbor language, which I'm sure you're all familiar with. Management may make forward-looking statements, including guidance and underlying assumptions. Forward-looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. For a further discussion of risks related to our business, see our filings with the SEC. This call will contain non-GAAP financial measures, such as adjusted gross profit, adjusted gross margin, adjusted net income, adjusted EBITDA, and adjusted EBITDA margins. Reconciliations of these non-GAAP measures to the most comparable GAAP measure are included in the earnings release furnished to the SEC and available on our website. Now, I would like to turn the call over to Brent Saunders, Executive Chairman of the Beauty Health Company.

Thank you, Don, and good afternoon, everyone. Thank you for joining us for a discussion of today's third quarter results. As I'm sure you saw in today's press release, I will be stepping into the role as the company's interim CEO effective January 1st, 2022. As part of this transition, Quinn will remain CEO through year end, at which point I will assume additional responsibilities of the CEO until a permanent successor is named. On behalf of the board, I want to thank Clint for his dedication and commitment to beauty health over the past five years. He has been a driving force behind the company's success, navigating beauty health through COVID as well as our business combination in May. Under his leadership, beauty health has become a solid platform for us to build upon as we look towards our next pillar of growth and begin to accelerate our acquisitions. Given these objectives and the strength of beauty health, Clint and the board felt that this was the ideal time to begin the CEO transition. We thank him for his contributions. While Clint and I have been working closely over the past few quarters, I'm excited to step in more fully and work with the team to continue to drive growth and focus on our strategic initiatives. This is a compelling time and I am excited about our future. The company has a strong foundation and I look forward to the next chapter and the significant growth opportunities we have ahead. I would now like to turn the call over to Clint.